| Molecular Formula: | |
|---|---|
| Molecular Formula | C28H32N4O5S |
| Molecular Weight: | |
| Molecular Weight | 536.64 |
| COA: | |
| COA | Inquire |
| Targets: | |
| Targets | Endothelin Receptor |
| Description: | |
| Description | Edonentan, also known as BMS-207940, is a very potent and selective ETA endothelin receptor antagonist (Ki= 10 pM) that shows 80000-fold selective for ETA vs ETB. |
| Purity: | |
|---|---|
| Purity | 95% |
| Appearance: | |
| Appearance | Solid powder |
| Synonyms: | |
| Synonyms | N-[[2-[2-[(4,5-dimethyl-1,2-oxazol-3-yl)sulfamoyl]phenyl]-5-(1,3-oxazol-2-yl)phenyl]methyl]-N,3,3-trimethylbutanamide; Edonentan; UNII-S5016F5ZH4 ;CHEMBL383581; 210891-04-6; UNII-2CCC8CH216; Edonentan[INN]； 210891-04-6 (Edonentan); 264609-13-4 (Edonentan hydrate) |
| MSDS: | |
| MSDS | Inquire |
| Quantity: | |
|---|---|
| Quantity | Data not available, please inquire. |
| InChIKey: | |
| InChIKey | ORJRYNKVKJAJPY-UHFFFAOYSA-N |
| InChI: | |
| InChI | InChI=1S/C28H32N4O5S/c1-18-19(2)37-30-26(18)31-38(34,35)24-10-8-7-9-23(24)22-12-11-20(27-29-13-14-36-27)15-21(22)17-32(6)25(33)16-28(3,4)5/h7-15H,16-17H2,1-6H3,(H,30,31) |
| Canonical SMILES: | |
| Canonical SMILES | CC1=C(ON=C1NS(=O)(=O)C2=CC=CC=C2C3=C(C=C(C=C3)C4=NC=CO4)CN(C)C(=O)CC(C)(C)C)C |
Related Endothelin Receptor Products
Bosentan
(CAS: 147536-97-8)
Bosentan is an endothelin (ET) receptor antagonist for ET-A and ET-B with Ki of 4.7 nM and 95 nM, respectively.
Avosentan
(CAS: 290815-26-8)
Avosentan, also known as SPP301, R-639, and RO 67-0565, is a potent and selective endothelin receptor(ETA receptor) antagonist.
BMS-193884
(CAS: 176960-47-7)
BMS-193884, an oxazol derivative, has been found to be an endothelin A receptor antagonist and was once studied in the treatmen of heart failure.
BQ 788 sodium salt
(CAS: 156161-89-6)
BQ 788 sodium salt is a potent, selective ETB receptor antagonist (IC50 = 1.2 nM) without significant activity on ETA receptor (IC50= 1300 nM).
SB-209670
(CAS: 157659-79-5)
SB-209670 has been found to be an endothelin receptor antagonist that was once studied against arrhythmias and hypertension.
Macitentan
(CAS: 441798-33-0)
Macitentan is an orally available dual endothelin receptor (ETR) antagonist with potential antihypertensive and antineoplastic activity.
FR 139317
(CAS: 142375-60-8)
FR 139317 is a selective Endothelin A receptor antagonist originated by Fujisawa. (Ki values are 1 nM and 7.3 μM at ETA and ETB subtypes respectively). No devel...
CI 1020
(CAS: 162256-50-0)
CI 1020 has been found to be a novel endothelin-A receptor antagonist and could be used as an antihypertensive agent.
Edonentan
(CAS: 210891-04-6)
Edonentan, also known as BMS-207940, is a very potent and selective ETA endothelin receptor antagonist (Ki= 10 pM) that shows 80000-fold selective for ETA vs ET...
Sitaxentan sodium
(CAS: 210421-74-2)
Sitaxentan sodium inhibits ET-1-induced stimulation of phosphoinositide turnover with a Ki of 0.69 nM and a pA2 of 8.0.
Endothelin 1 swine, human
(CAS: 117399-94-7)
Endothelin 1 (swine, human), a vasoconstrictor increased in plasma and explants of patients with uterine leiomyomas, is a synthetic peptide with the sequence of...
Sparsentan
(CAS: 254740-64-2)
Sparsentan, also known as RE-021, BMS346567, is a dual antagonist of both angiotensin II and endothelin A receptor antagonist.
N-Despropyl-macitentan
(CAS: 1103522-45-7)
N-Despropyl-macitentan, an active metabolite of Macitentan, is a dual ET receptor antagonist with longer half-life than Macitentan. It has been proved to be eff...
BMS 182874
(CAS: 153042-42-3)
BMS 182874 is an endothelin receptor antagonist used as an antihypertensive agent.
Sitaxsentan
(CAS: 184036-34-8)
Sitaxsentan, also called as IPI 1040 or TBC 11251, is a potent orally bioactive ET receptor antagonist that has a long duration of action (t1/2, 5–7 hours) and ...
T-0201 Sodium
(CAS: 188307-16-6)
The sodium salt form of T-0201 which has been found to be an Endothelin A receptor antagonist that could be used as as anti-ischaemic agent and was once studied...
IRL-2500
(CAS: 169545-27-1)
IRL-2500, an indol derivative, has been found to be an endothelin B receptor antagonist that was once studied in hypertension.
BMS-248360
(CAS: 254737-87-6)
BMS-248360 is a first orally active generation dual action receptor antagonist. BMS-248360 antagonized both Ang II AT1 and endothelin ETA receptors (AT1 IC50 = ...
Endothelin 2 (human)
(CAS: 123562-20-9)
Endothelin 2 is a ligand for the endothelin (ET) receptors and a potent vasoconstrictor mainly found in the kidney and intestine.
Tezosentan
(CAS: 180384-57-0)
Tezosentan, also known as RO 610612 and Veletri, is a potent dual endothelian (ETA/ETB) receptor antagonist optimized from Bosentan (B675900). It acts as a vaso...
Chemical Structure